Unique insights gained from multiple NASH studies

Modern challenges in the NASH clinical landscape have not diminished, but we have gained valuable, experience-based insight and extensive data on screening, recruitment, and dropout to deliver more efficient and expedited trials. In this asset, we summarize the key lessons we've learned after 14 trials over the last four years.